Luca Lanino

15PUBLICATIONS
184CO-AUTHORS
Predictive and prognostic markersMedical mycologyGene and molecular therapyHaematological tumoursData mining and knowledge discovery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 30, 2026
ASSESSMENT OF THE IPSS-M IN CHRONIC MYELOMONOCYTIC LEUKEMIA.

|Jul 17, 2026
Comprehensive analysis of prognostic factors in myelodysplastic syndromes with isolated deletion of chromosome 5q.

|Jun 29, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.

|Apr 11, 2026
CMML2AML: machine-learning discovery of co-mutations and specific single mutations predictive of blast transformation in chronic myelomonocytic leukemia.

Saubia Fathima, Lior Rokach, Muhammad Yousuf

|Mar 27, 2026
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia.

Luca Lanino, Anthony M Hunter, Nico Gagelmann

|Mar 06, 2026
Performance of molecular scoring systems in hypomethylating agent-treated myelodysplastic neoplasms.

Kelly S Chien, Ziyi Li, Luca Lanino

Pageof 3

Frequent Collaborators

12 joint publications

Matteo Giovanni Della Porta

9 joint publications

Valeria Santini

8 joint publications

Saverio D'Amico

7 joint publications

Maria Diez-Campelo